Multiple Sclerosis Pathology: Evolution of Pathogenetic Concepts (Q22242303)

PubMed

PubMed publication ID

16196388

ENCEPHALITIS PERIAXIALIS CONCENTRICA

7 February 2023

language of work or name

English

0 references

publication date

July 2005

0 references

1 reference

0 references

0 references

217-222

0 references

217-22

0 references

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

Axonal pathology in multiple sclerosis. A historical note

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Pathogenesis of multiple sclerosis: the eyes only see what the mind is prepared to comprehend

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Multiple sclerosis: remyelination of nascent lesions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

The adhesion molecule and cytokine profile of multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Immunoglobulin-containing cells in multiple-sclerosis plaques

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Spinal cord axonal loss in multiple sclerosis: a post-mortem study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Axonal transection in the lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Chemokines--chemotactic cytokines that mediate inflammation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

A controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Ultrastructural study of remyelination in an experimental lesion in adult cat spinal cord

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

A search for virus in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Multiple sclerosis. Pathology of recurrent lesions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Axonal damage in acute multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Imaging axonal damage of normal-appearing white matter in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Primary progressive multiple sclerosis: a 5-year clinical and MR study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

In-situ characterization of mononuclear cell infiltrates in lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic Lesions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

The distribution of plaques in the cerebrum in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

MRI dynamics of brain and spinal cord in progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00523.X

7 January 2021

10.1111/J.1750-3639.2005.TB00523.X

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

16196388

1 reference

Consolidated OpenCitations Corpus – April 2017